- idUS
- Listar por autor
Listar por autor "Scolyer, Richard A."
Mostrando ítems 1-1 de 1
-
Artículo
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
Schadendorf, Dirk; Luke, Jason John; Ascierto, Paolo A.; Long, Georgina V.; Rutkowski, Piotr; Khattak, Adnan; Cruz Merino, Luis de la; Scolyer, Richard A. (BMC, 2024)Background Adjuvant pembrolizumab significantly improved recurrence-free survival (RFS) and distant metastasis-free survival ...